Table 2.

Continuous glucose monitoring median, minimum, maximum glucose values, and outcomes of glycemic variability in the study participants

			Descriptive outcomes, mmol/L			Glycemic variability
Participant	Time points, n	Days/ nights, n	Median, mmol/L	Min, mmol/L	Max, mmol/L	SD, mmol/L	Variance, mmol2/L2	CV, %
001
24 hours	2845	10	6.2	2.8	11.0	1.4	1.9	21.3
1:00-5:00 am	480	10	7.2	4.9	11.0	1.1	1.3	15.7
002
24 hours	1206	4	5.4	2.2	9.3	1.2	1.4	21.5
1:00-5:00 am	192	4	5.0	3.3	7.7	0.8	0.7	16.6
004
24 hours	2802	10	5.4	2.4	9.2	1.0	1.0	17.9
1:00-5:00 am	480	10	5.4	3.7	8.2	0.7	0.5	13.1
006
24 hours	2612	9	6.7	2.8	17.0	1.7	2.8	24.7
1:00-5:00 am	437	9	6.8	3.7	10.0	1.2	1.3	16.8
007a
24 housr	2207	8	7.6	3.7	13.0	1.5	2.2	19.2
1:00-5:00 am	384	8	8.0	4.6	12.4	1.7	2.8	20.6
009a
24 hours	2851	10	5.4	3.0	10.4	1.3	1.6	22.2
1:00-5:00 am	480	10	5.1	3.7	7.0	0.6	0.3	11.5
014
24 hours	2480	9	5.6	2.7	13.8	1.7	2.9	28.5
1:00-5:00 am	432	9	5.0	3.2	10.0	1.4	1.9	25.3
015
24 hours	2856	10	5.7	2.2	13.9	1.9	3.5	32.0
1:00-5:00 am	490	10	4.9	2.4	8.9	1.6	2.6	30.6
017a
24 hours	2713	10	5.7	2.2	10.0	1.1	1.2	19.0
1:00-5:00 am	480	10	5.9	3.2	8.3	0.9	0.8	15.0
020
24 hours	2932	10	5.7	3.2	9.7	1.0	0.9	16.7
1:00-5:00 am	461	10	5.9	3.4	8.2	0.8	0.7	14.0
GSDIab
24 hours	25 504	90	5.9 (5.5-6.4)	2.7 (2.4-3.0)	11.7 (10.1-13.3)	1.4 (1.2-1.6)c	1.9 (1.4-2.5)c	22.3 (20.0-24.6)c
1:00-5:00 am	4264	90	5.9 (5.3-6.6)	3.6 (3.2-4.1)	9.2 (8.1-10.3)c	1.1 (0.8-1.3)c	1.3 (0.7-1.9)	17.9 (14.2-21.6)c
Healthy volunteersb
24 hours	27 153	96	5.7 (5.4-6.0)	2.8 (2.4-3.2)	10.4 (9.9-10.9)	1.0 (0.9-1.1)	1.0 (0.8-1.1)	16.5 (15.8-17.2)
1:00-5:00 am	4616	96	5.6 (5.3-6.0)	3.7 (3.1-4.3)	7.3 (6.6-8.0)	0.6 (0.4-0.8)	0.5 (0.1-0.8)	10.7 (8.2-13.2)

Abbreviation: CV, coefficient of variation; GSDIa, glycogen storage disease type Ia.

^aGSDIa patients receiving continuous nocturnal gastric drip-feeding.

^bFor descriptive and glycemic variability measures mean (95% CI) are shown.

^cSignificant difference between GSDIa patients and healthy volunteers.